tiprankstipranks
Zoetis (CH:ZOE)
NYSE:ZOE
Switzerland Market
ZOE
Zoetis
RESEARCH TOOLSreports

Zoetis (ZOE) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

ZOE Analyst Ratings

Moderate Buy
10Ratings
Moderate Buy
5 Buy
5 Hold
0 Sell
Based on 10 analysts giving stock ratings to
Zoetis
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ZOE Stock 12 Month Forecast

Average Price Target

$93.43
Based on 10 Wall Street analysts offering 12 month price targets for Zoetis in the last 3 months. The average price target is $93.43 with a high forecast of $121.26 and a low forecast of $76.80. The average price target represents a ― change from the last price of ―.
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
Highest Price Target$121.26Average Price Target$93.43Lowest Price Target$76.80
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on CH:ZOE
Michael Ryskin
Bank of America Securities
Bank of America Securities
CHF87.31
Hold
―
Reiterated
06/16/26
Zoetis Kept at Hold as Competitive Pressures Mount and Innovation Lags; Price Target Maintained at $108
William Blair Analyst forecast on CH:ZOE
Brandon Vazquez
William Blair
William Blair
―
Buy
―
Reiterated
06/03/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Argus Research Analyst forecast on CH:ZOE
Jasper Hellweg
Argus Research
Argus Research
―
Hold
―
Downgraded
05/26/26
Zoetis downgraded to Hold from Buy at ArgusZoetis downgraded to Hold from Buy at Argus
Stifel Nicolaus Analyst forecast on CH:ZOE
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
CHF84.88→CHF76.8
Hold
―
Reiterated
05/22/26
Analysts Conflicted on These Healthcare Names: Zoetis (NYSE: ZTS), Cencora (NYSE: COR) and Corbus Pharmaceuticals (NASDAQ: CRBP)
Citi Analyst forecast on CH:ZOE
Daniel Grosslight
Citi
Citi
CHF117.22→CHF90.54
Buy
―
Reiterated
05/18/26
Zoetis price target lowered to $112 from $145 at CitiZoetis price target lowered to $112 from $145 at Citi
Morgan Stanley Analyst forecast on CH:ZOE
Erin Wright
Morgan Stanley
Morgan Stanley
CHF92.96
Buy
―
Assigned
05/15/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Zoetis (NYSE: ZTS), Sarepta Therapeutics (NASDAQ: SRPT) and GoodRx Holdings (NASDAQ: GDRX)
J.P. Morgan Analyst forecast on CH:ZOE
Chris Schott
J.P. Morgan
J.P. Morgan
CHF153.59→CHF105.09
Buy
―
Assigned
05/08/26
Zoetis price target lowered to $130 from $190 at JPMorganZoetis price target lowered to $130 from $190 at JPMorgan
UBS Analyst forecast on CH:ZOE
Andrea Alfonso
UBS
UBS
CHF105.09→CHF80.03
Hold
―
Reiterated
05/08/26
Zoetis price target lowered to $99 from $130 at UBSZoetis price target lowered to $99 from $130 at UBS
KeyBanc Analyst forecast on CH:ZOE
Scott Schoenhaus
KeyBanc
KeyBanc
―
Hold
―
Reiterated
05/08/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Evolent Health (NYSE: EVH), Zoetis (NYSE: ZTS) and ICU Medical (NASDAQ: ICUI)
TD Cowen Analyst forecast on CH:ZOE
Steve Scala
TD Cowen
TD Cowen
CHF121.26
Buy
―
Reiterated
05/07/26
TD Cowen Sticks to Its Buy Rating for Zoetis (ZTS)
HSBC Analyst forecast on CH:ZOE
Sidharth Sahoo
HSBC
HSBC
CHF97.4→CHF113.17
Buy
―
Reiterated
03/10/26
Nephron Analyst forecast on CH:ZOE
Thomas DeBourcy
Nephron
Nephron
CHF105.9
Hold
―
Downgraded
03/05/26
Zoetis downgraded to Hold from Buy at Nephron ResearchZoetis downgraded to Hold from Buy at Nephron Research
BTIG Analyst forecast on CH:ZOE
Mark Massaro
BTIG
BTIG
CHF129.34
Buy
―
Reiterated
02/26/26
Zoetis (ZTS) Receives a Buy from BTIG
Barclays Analyst forecast on CH:ZOE
Glen Santangelo
Barclays
Barclays
CHF109.94
Hold
―
Reiterated
02/18/26
Barclays Keeps Their Hold Rating on Zoetis (ZTS)
Piper Sandler Analyst forecast on CH:ZOE
David Westenberg
Piper Sandler
Piper Sandler
CHF153.59→CHF109.13
Hold
―
Downgraded
01/22/26
Zoetis downgraded to Neutral from Overweight at Piper SandlerZoetis downgraded to Neutral from Overweight at Piper Sandler
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on CH:ZOE
Michael Ryskin
Bank of America Securities
Bank of America Securities
CHF87.31
Hold
―
Reiterated
06/16/26
Zoetis Kept at Hold as Competitive Pressures Mount and Innovation Lags; Price Target Maintained at $108
William Blair Analyst forecast on CH:ZOE
Brandon Vazquez
William Blair
William Blair
―
Buy
―
Reiterated
06/03/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Argus Research Analyst forecast on CH:ZOE
Jasper Hellweg
Argus Research
Argus Research
―
Hold
―
Downgraded
05/26/26
Zoetis downgraded to Hold from Buy at ArgusZoetis downgraded to Hold from Buy at Argus
Stifel Nicolaus Analyst forecast on CH:ZOE
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
CHF84.88→CHF76.8
Hold
―
Reiterated
05/22/26
Analysts Conflicted on These Healthcare Names: Zoetis (NYSE: ZTS), Cencora (NYSE: COR) and Corbus Pharmaceuticals (NASDAQ: CRBP)
Citi Analyst forecast on CH:ZOE
Daniel Grosslight
Citi
Citi
CHF117.22→CHF90.54
Buy
―
Reiterated
05/18/26
Zoetis price target lowered to $112 from $145 at CitiZoetis price target lowered to $112 from $145 at Citi
Morgan Stanley Analyst forecast on CH:ZOE
Erin Wright
Morgan Stanley
Morgan Stanley
CHF92.96
Buy
―
Assigned
05/15/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Zoetis (NYSE: ZTS), Sarepta Therapeutics (NASDAQ: SRPT) and GoodRx Holdings (NASDAQ: GDRX)
J.P. Morgan Analyst forecast on CH:ZOE
Chris Schott
J.P. Morgan
J.P. Morgan
CHF153.59→CHF105.09
Buy
―
Assigned
05/08/26
Zoetis price target lowered to $130 from $190 at JPMorganZoetis price target lowered to $130 from $190 at JPMorgan
UBS Analyst forecast on CH:ZOE
Andrea Alfonso
UBS
UBS
CHF105.09→CHF80.03
Hold
―
Reiterated
05/08/26
Zoetis price target lowered to $99 from $130 at UBSZoetis price target lowered to $99 from $130 at UBS
KeyBanc Analyst forecast on CH:ZOE
Scott Schoenhaus
KeyBanc
KeyBanc
―
Hold
―
Reiterated
05/08/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Evolent Health (NYSE: EVH), Zoetis (NYSE: ZTS) and ICU Medical (NASDAQ: ICUI)
TD Cowen Analyst forecast on CH:ZOE
Steve Scala
TD Cowen
TD Cowen
CHF121.26
Buy
―
Reiterated
05/07/26
TD Cowen Sticks to Its Buy Rating for Zoetis (ZTS)
HSBC Analyst forecast on CH:ZOE
Sidharth Sahoo
HSBC
HSBC
CHF97.4→CHF113.17
Buy
―
Reiterated
03/10/26
Nephron Analyst forecast on CH:ZOE
Thomas DeBourcy
Nephron
Nephron
CHF105.9
Hold
―
Downgraded
03/05/26
Zoetis downgraded to Hold from Buy at Nephron ResearchZoetis downgraded to Hold from Buy at Nephron Research
BTIG Analyst forecast on CH:ZOE
Mark Massaro
BTIG
BTIG
CHF129.34
Buy
―
Reiterated
02/26/26
Zoetis (ZTS) Receives a Buy from BTIG
Barclays Analyst forecast on CH:ZOE
Glen Santangelo
Barclays
Barclays
CHF109.94
Hold
―
Reiterated
02/18/26
Barclays Keeps Their Hold Rating on Zoetis (ZTS)
Piper Sandler Analyst forecast on CH:ZOE
David Westenberg
Piper Sandler
Piper Sandler
CHF153.59→CHF109.13
Hold
―
Downgraded
01/22/26
Zoetis downgraded to Neutral from Overweight at Piper SandlerZoetis downgraded to Neutral from Overweight at Piper Sandler
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Zoetis

3 Months
Erin WrightMorgan Stanley
Success Rate
13/23 ratings generated profit
57%
Average Return
+1.78%
Copying Erin Wright's trades and holding each position for 3 Months would result in 56.52% of your transactions generating a profit, with an average return of +1.78% per trade.
1 Year
Erin WrightMorgan Stanley
Success Rate
12/23 ratings generated profit
52%
Average Return
-0.28%
Copying Erin Wright's trades and holding each position for 1 Year would result in 52.17% of your transactions generating a profit, with an average return of -0.28% per trade.
2 Years
Steve ScalaTD Cowen
Success Rate
9/18 ratings generated profit
50%
Average Return
+6.68%
Copying Steve Scala's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +6.68% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ZOE Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
2
2
2
4
3
Buy
11
5
7
5
5
Hold
12
11
9
10
10
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
25
18
18
19
18
In the current month, ZOE has received 8 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. ZOE average Analyst price target in the past 3 months is 93.43.
Each month's total comprises the sum of three months' worth of ratings.

ZOE Financial Forecast

ZOE Earnings Forecast

Next quarter’s earnings estimate for ZOE is $1.47 with a range of $1.40 to $1.53. The previous quarter’s EPS was $1.21. ZOE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ZOE has Performed in-line its overall industry.
Next quarter’s earnings estimate for ZOE is $1.47 with a range of $1.40 to $1.53. The previous quarter’s EPS was $1.21. ZOE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ZOE has Performed in-line its overall industry.

ZOE Sales Forecast

Next quarter’s sales forecast for ZOE is $1.98B with a range of $1.92B to $2.00B. The previous quarter’s sales results were $1.79B. ZOE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ZOE has Performed in-line its overall industry.
Next quarter’s sales forecast for ZOE is $1.98B with a range of $1.92B to $2.00B. The previous quarter’s sales results were $1.79B. ZOE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ZOE has Performed in-line its overall industry.

ZOE Stock Forecast FAQ

What is CH:ZOE’s average 12-month price target, according to analysts?
Based on analyst ratings, Zoetis’s 12-month average price target is 93.43.
    What is CH:ZOE’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:ZOE, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Zoetis a Buy, Sell or Hold?
        Zoetis has a consensus rating of Moderate Buy, which is based on 5 buy ratings, 5 hold ratings and 0 sell ratings.
          What is Zoetis’s share price target?
          The average share price target for Zoetis is 93.43. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $121.26 ,and the lowest forecast is $76.80. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Zoetis?
            Zoetis’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
              How can I buy shares of Zoetis?
              To buy shares of CH:ZOE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.